Coterra Energy price target raised to $38 from $33 at...
Raymond James analyst John Freeman raised the firm’s price target on Coterra Energy (CTRA) to $38 from $33 and keeps an Outperform rating on the shares. Coterra Energy posted Q1...
Raymond James analyst John Freeman raised the firm’s price target on Coterra Energy (CTRA) to $38 from $33 and keeps an Outperform rating on the shares. Coterra Energy posted Q1...
Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started coverage of Avidity Biosciences, Inc. (NASDAQ:RNA), with a Strong Buy rating...